AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Wsol, V Kral, R Skalova, L Szotakova, B Trejtnar, F Flieger, M
Citation: V. Wsol et al., Stereospecificity and stereoselectivity of flobufen metabolic profile in mate rats in vitro and in vivo: Phase I of biotransformation, CHIRALITY, 13(10), 2001, pp. 754-759

Authors: Skalova, L Szotakova, B Lamka, J Kral, R Vankova, I Baliharova, V Wsol, V
Citation: L. Skalova et al., Biotransformation of flobufen enantiomers in ruminant hepatocytes and subcellular fractions, CHIRALITY, 13(10), 2001, pp. 760-764

Authors: Skalova, L Szotakova, B Machala, M Neca, J Soucek, P Havlasova, J Wsol, V Kridova, L Kvasnickova, E Lamka, J
Citation: L. Skalova et al., Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama), CHEM-BIO IN, 137(2), 2001, pp. 155-167

Authors: Wsol, V Szotakova, B Skalova, L Cepkova, H Kvasnickova, E
Citation: V. Wsol et al., The main metabolic pathway of oracin, a new potential cytostatic drug, in human liver microsomes and cytosol: Stereoselectivity of reoxidation of theprincipal metabolite 11-dihydrooracin to oracin, ENANTIOMER, 5(3-4), 2000, pp. 263-270

Authors: Skalova, L Szotakova, B Wsol, V Kral, R Baliharova, V Lamka, J
Citation: L. Skalova et al., Activity, stereospecificity, and stereoselectivity of microsomal enzymes in dependence on storage and freezing of rat liver samples, CHIRALITY, 12(9), 2000, pp. 649-653

Authors: Skalova, L Szotakova, B Machala, M Neca, J Lamka, J Duchacek, L Kvasnickova, E
Citation: L. Skalova et al., Effect of ivermectin on induction of cytochromes P450 in male rats, CHEM PAP-CH, 54(4), 2000, pp. 249-253

Authors: Szotakova, B Skalova, L Wsol, V Kvasnieckova, E
Citation: B. Szotakova et al., Reduction of the potential anticancer drug oracin in the rat liver in-vitro, J PHARM PHA, 52(5), 2000, pp. 495-500

Authors: Skalova, L Nobilis, M Szotakova, B Wsol, V Kubicek, V Baliharova, V Kvasnickova, E
Citation: L. Skalova et al., Effect of substituents on microsomal reduction of benzo(c)fluorene N-oxides, CHEM-BIO IN, 126(3), 2000, pp. 185-200

Authors: Kvasnickova, E Szotakova, B Wsol, V Trejtnar, F Skalova, L Hais, IM Kuchar, M Poppova, M
Citation: E. Kvasnickova et al., Metabolic pathways of flobufen - a new antirheumatic and antiarthritic drug. Interspecies comparison, EXP TOX PAT, 51(4-5), 1999, pp. 352-356

Authors: Szotakova, B Wsol, V Skalova, L Kvasnickova, E
Citation: B. Szotakova et al., Role of cytochrome P4501A in biotransformation of the potential anticancerdrug oracin, EXP TOX PAT, 51(4-5), 1999, pp. 428-431

Authors: Trejtnar, F Skalova, L Szotakova, B Wsol, V
Citation: F. Trejtnar et al., Use of rat hepatocytes immobilized in agarose gel threads for biosynthesisof metabolites of potential cytostatics, EXP TOX PAT, 51(4-5), 1999, pp. 432-435

Authors: Wsol, V Skalova, L Szotakova, B Trejtnar, F Kvasnickova, E
Citation: V. Wsol et al., Sex differences in stereospecificity of oracin reductases in rat in vitro and in vivo, CHIRALITY, 11(5-6), 1999, pp. 505-509

Authors: Skalova, L Wsol, V Szotakova, B Kvasnickova, E
Citation: L. Skalova et al., A comparison between stereospecificity of oracin reduction and stereoselectivity of oxidation of 11-dihydrooracin enantiomers in vitro in rat and guinea pig, CHIRALITY, 11(5-6), 1999, pp. 510-515

Authors: Trejtnar, F Wsol, V Szotakova, B Skalova, L Pavek, P Kuchar, M
Citation: F. Trejtnar et al., Stereoselective pharmacokinetics of flobufen in rats, CHIRALITY, 11(10), 1999, pp. 781-786
Risultati: 1-14 |